Partnership expands CNF education initiatives, diagnostics access, and resources for families & healthcare professionals across pediatric onset neurologic care
Ambry Genetics (NASDAQ:TEM)
LEXINGTON, KY, UNITED STATES, March 11, 2026 /EINPresswire.com/ -- The Child Neurology Foundation (CNF) today announced Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), as a Champion Level Partner, supporting CNF’s education initiatives and critical resources for families and healthcare professionals across the child neurology community.








